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Moreira, Thiago Santos, Monica Akemi Sato, Ana Carolina
Thomaz Takakura, Jose´ Vanderlei Menani, and Eduardo Co-
lombari. Role of pressor mechanisms from the NTS and CVLM in
control of arterial pressure. Am J Physiol Regul Integr Comp
Physiol 289: R1416 –R1425, 2005. First published July 28, 2005;
doi:10.1152/ajpregu.00053.2005.—In the present study, we inves-
tigated the effects of inhibition of the caudal ventrolateral medulla
(CVLM) with the GABAA agonist muscimol combined with the
blockade of glutamatergic mechanism in the nucleus of the solitary
tract (NTS) with kynurenic acid (kyn) on mean arterial pressure
(MAP), heart rate (HR), and regional vascular resistances. In male
Holtzman rats anesthetized intravenously with urethane/chloralose,
bilateral injections of muscimol (120 pmol) into the CVLM or
bilateral injections of kyn (2.7 nmol) into the NTS alone increased
MAP to 186  11 and to 142  6 mmHg, respectively, vs. control:
105  4 mmHg; HR to 407  15 and to 412  18 beats per minute
(bpm), respectively, vs. control: 352  12 bpm; and renal, mes-
enteric and hindquarter vascular resistances. However, in rats with
the CVLM bilaterally blocked by muscimol, additional injections
of kyn into the NTS reduced MAP to 88  5 mmHg and mesenteric
and hindquarter vascular resistances below control baseline levels.
Moreover, in rats with the glutamatergic mechanisms of the NTS
blocked by bilateral injections of kyn, additional injections of
muscimol into the CVLM also reduced MAP to 92  2 mmHg and
mesenteric and hindquarter vascular resistances below control
baseline levels. Simultaneous blockade of NTS and CVLM did not
modify the increase in HR but also abolished the increase in renal
vascular resistance produced by each treatment alone. The results
suggest that important pressor mechanisms arise from the NTS and
CVLM to control vascular resistance and arterial pressure under
the conditions of the present study.
ventrolateral medulla; ; -aminobutyric acid; L-glutamate; musci-
mol; sympathetic system
THE MEDULLARY CIRCUIT related to cardiovascular control in-
volves the nucleus of the solitary tract (NTS), nucleus ambig-
uous, and ventrolateral medulla (rostral and caudal) (8, 15, 17).
The NTS is the site of the first synapse of the viscerosensory
afferents in the brain stem, including those related to cardio-
vascular baroreceptor and chemoreceptor afferents. The neu-
rotransmitter released by these afferents in the NTS is sug-
gested to be L-glutamate (8, 15, 16, 32, 48). From the NTS, the
baroreceptor afferent signals project to the caudal ventrolateral
medulla (CVLM) (45, 47). Through GABAergic mechanisms,
the CVLM inhibits neurons in the rostral ventrolateral medulla
(RVLM) that innervate the preganglionic sympathetic neurons
involved in controlling the heart and vascular beds (5, 15, 28,
29, 36, 37). Disinhibition of the RVLM via deactivation of
CVLM by electrolytic lesions or injections of the GABAA
receptor agonist muscimol, or the blockade of GABAergic
transmission in the RVLM, results in sustained sympathoexci-
tation and increase in arterial pressure and heart rate (4, 14,
46). Similar to the deactivation of the CVLM, the blockade of
the NTS with injections of muscimol or the ionotropic
glutamatergic antagonist kynurenic acid (kyn) also produces
sympathoexcitation and increases arterial pressure and heart
rate (18).
Parallel to the inhibitory mechanisms, the RVLM also re-
ceives important excitatory projections (17, 20, 24, 26). Ana-
tomical and immunohistochemical studies have shown that the
NTS sends monosynaptic connections to the RVLM (13, 21,
35, 39, 41) and these projections from the NTS to the RVLM
may convey peripheral chemoreceptor signals (30, 31, 49). The
existence of pressor mechanisms in the NTS is supported by
the increase in arterial pressure produced by L-glutamate in-
jections into the NTS in awake rats (9, 33). Although L-
glutamate injected into the NTS in anesthetized rats usually
reduces arterial pressure, similar to baroreflex activation, L-
glutamate into the NTS induces pressor responses in anesthe-
tized rats after the inhibition of the CVLM with muscimol (49).
This pressor response to L-glutamate into the NTS in anesthe-
tized rats is abolished by the blockade of excitatory amino acid
(EAA) receptors in the RVLM, which suggests the existence of
a pressor pathway from the NTS to the RVLM (50, 54).
Besides the inhibitory projection, there are some studies that
suggest that the CVLM by direct or indirect projections may
activate RVLM neurons (26, 38). In spite of some controver-
sies (25), Ito and Sved (26) have shown that the blockade of the
EAA receptors by bilateral injections of kyn into the RVLM
combined with the inhibition of the CVLM with bilateral
injections of muscimol reduced arterial pressure to a level
similar to that produced by complete autonomic blockade,
suggesting that the RVLM receives important tonic excitatory
drive. However, bilateral injections of kyn alone into the
RVLM in rats do not significantly change resting arterial
pressure, which indicate that these excitatory mechanisms are
not active in resting conditions. According to Ito and Sved
(26), under resting conditions the excitatory drive to the
RVLM is counterbalanced by the activation of the CVLM
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inhibitory mechanisms that, in turn, is also activated by signals
under control of the RVLM excitatory drive. When the inhib-
itory mechanism is blocked by injections of muscimol into the
CVLM, the excitatory mechanisms that reach the RVLM
are released and sympathetic activity and arterial pressure
increase (26).
Therefore, according to the work of Ito and Sved (26), the
deactivation of the inhibitory influences that reach the RVLM
by blocking the CVLM with muscimol or the EAA receptors
with kyn into NTS increases sympathetic activity, arterial
pressure, and heart rate. Additional studies have suggested that
the RVLM also receives excitatory projections from the NTS
and from the CVLM. Considering that the relative importance
of the excitatory and inhibitory signals from the CVLM and
NTS to the RVLM for cardiovascular regulation is still not
completely clear, in the present study, we investigated the
effects produced by the inhibition of the CVLM with muscimol
combined with the blockade of EAA receptors in the NTS with
kyn on mean arterial pressure (MAP), heart rate (HR) and
renal, mesenteric and hindquarter vascular resistances. To
better compare the relative importance of the mechanisms
present in each area for cardiovascular control, two sequences
of treatments were tested in different rats: in one group of rats
the first treatment was muscimol into the CVLM, and the
second treatment, performed 10 min later, was kyn into the
NTS; in another group of rats, the first treatment was kyn into
the NTS followed 10 min later by muscimol into the CVLM.
MATERIALS AND METHODS
Surgical procedures. All experiments were performed in accor-
dance with the Brazilian National Health and Medical Research
Council code of practice for the care and use of animals for scientific
purposes and were approved by the Animal Experimentation Ethics
Committee of the Federal University of Sa˜o Paulo, School of Medi-
cine.
Male Holtzman rats weighing 300–350 g were used. One day
before the experiment, the rats were anesthetized with ketamine (80
mg/kg body wt) combined with xylazine (7 mg/kg body wt), and the
femoral artery and vein were cannulated for arterial pressure mea-
surement and drug administration, respectively. The arterial and
venous catheters (PE-10 connected to PE-50) were tunneled subcuta-
neously and fixed on the back of the rat with suture thread. On the next
day, immediately before the experiments, the animals were anesthe-
tized with urethane (1.0 g/kg iv) combined with -chloralose (60
mg/kg iv). A midline laparotomy was performed and miniature pulsed
Doppler flow probes were placed around the renal artery, superior
mesenteric artery, and lower abdominal aorta for measurement of
renal, mesenteric, and hindquarter blood flows, respectively. The
probes were fixed to the surrounding tissues with suture thread, and
the animals were immediately placed in a stereotaxic apparatus in a
prone position with the incisor bar at 11 mm below the intra-aural line.
A partial occipital craniotomy was performed to expose the dorsal
surface of the caudal brain stem.
Arterial pressure, heart rate and regional blood flow recordings.
The catheter inserted into the femoral artery was connected to a P23
Db pressure transducer (Statham Gould) coupled to a preamplifier
(model ETH-200 Bridge Bio Amplifier, CB Sciences) connected to
the Powerlab computer recording system (model Powerlab 16SP,
ADInstruments) for measurement of pulsatile arterial pressure, MAP,
and HR. The flow probes were connected to a Doppler flowmeter
(Dept. of Bioengineering, University of Iowa, Iowa City, IA) also
coupled to the Powerlab computer recording system. Details of the
Doppler flow recording technique, including the reliability of the
method for estimation of flow velocity, have been described previ-
ously by Haywood and colleagues (22). Relative renal, mesenteric,
and hindquarter vascular resistance changes were calculated as the
ratio of MAP and Doppler shifts. Data from animals in which the
probes moved during the experiment were not considered for analysis.
The rectal temperature was maintained at 37°C with a thermostat-
ically controlled heating pad. During the surgical procedure or record-
ing period, if the animals were responsive to noxious toe pinch, a
supplementary dose of urethane (0.1 g/kg) combined with -chlora-
lose (20 mg/kg) was administered intravenously.
Central injections. Injections (50 nl, delivered over 5 s) of musci-
mol (120 pmol) or saline into the CVLM and kyn (2.7 nmol) or
vehicle into the intermediate regions of the NTS were performed
using the same single-barrel glass pipette (20 m tip diameter)
coupled to a pressure injection apparatus (PicoSpritzer II). An injec-
tion was first performed in one side; the pipette was withdrawn from
the brain and the contralateral injection was made; thus the two
injections were made1 min apart. The volume of each injection was
estimated from the displacement of the fluid meniscus in the pipette
using a calibrated reticule. Injections into the CVLM were made 0.5
mm rostral to the calamus scriptorius, 1.8 mm lateral to midline and
Fig. 1. A: photomicrograph of a coronal section of the brain stem showing the
typical bilateral injections into the intermediate region of the nucleus of the
solitary tract (NTS) and into the caudal ventrolateral medulla (CVLM). Arrows
indicate the center of the injections. B: diagrammatic composite of a transverse
section of the rat medulla showing the sites where muscimol and kyn were
injected approximately at the level 13.7 mm caudal to bregma according to
Paxinos and Watson (40). Solid triangles indicate the centers of injection sites
of kyn into the NTS (n  16) or muscimol into the CVLM (n  16), and open
triangles indicate the centers of injection sites into the neighboring regions of
the NTS (n  9) and CVLM (n  12). Amb, nucleus ambiguus; AP, area
postrema; cc, central canal; LRN, lateral reticular nucleus; X, dorsal motor
vagus nucleus; XII, hypoglossal nucleus.
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1.9 to 2.2 mm below the dorsal surface of the brain stem. Injections into
the NTS were made 0.5 mm rostral to the calamus scriptorius, 0.5 mm
lateral to midline, and 0.5 mm below the dorsal surface of the brain stem.
Drugs. Muscimol and kyn were purchased from Sigma Chemical.
Muscimol was dissolved in isotonic saline. Kyn was initially dissolved in
100 mM sodium bicarbonate (in a volume that corresponded to 10% of
the final volume) and then diluted with isotonic saline until reaching the
final volume. The pH of kynurenic acid solution was around 7.4.
Histology. At the end of the experiments, a 2% solution of Evans
blue was injected into the CVLM and NTS (50 nl) using the same
pipette that was previously used for drug injection. Saline followed by
10% buffered formalin was perfused through the heart. The brains
were removed, fixed in 10% formalin for at least 2 days, frozen, cut
coronally into 50-m sections and stained with Giemsa. The sections
were analyzed by light microscopy to confirm the injections bilater-
ally into the CVLM and NTS.
Statistical analysis. Data are expressed as means  SE. Statistical
analysis of baseline MAP, HR, and changes in vascular resistances
were performed using two-way ANOVA followed by the Student-
Newman-Keuls post hoc test. Significance level was set at P  0.05.
Experimental Protocols1
Effects of kynurenic acid into the NTS on MAP, HR, and regional
vascular resistances in rats pretreated with muscimol into the CVLM.
Blood flows, MAP and HR were continuously recorded during 60 min
and were analyzed at every 10 min starting the recording 10 min after
the connection of the arterial line to the pressure transducer. Control
(baseline) values were recorded for 10 min and were analyzed imme-
diately before bilateral injections of muscimol or saline into the
CVLM (first treatment). These values were used as reference to
calculate the changes produced by the treatments. Ten minutes after
muscimol or saline into the CVLM, kyn or vehicle was bilaterally
injected into the NTS and the cardiovascular responses were evaluated
during the next 40 min.
Four groups of animals (n 8 in each group) were used to investigate
the cardiovascular effects of the combination of injections of muscimol or
saline into the CVLM followed by injections of kyn or vehicle into the
NTS. In each rat, only one of the following combinations was tested: 1)
saline into the CVLM followed by vehicle into the NTS (control); 2)
saline into the CVLM followed by kyn into the NTS; 3) muscimol into
the CVLM followed by vehicle into the NTS; and 4) muscimol into the
CVLM followed by kyn into the NTS.
Effects of muscimol into the CVLM on MAP, HR, and regional
vascular resistances in rats pretreated with kynurenic acid into
the NTS. The protocol used was similar to that described above (item
1), except that the first treatment was kyn or vehicle into the NTS and
the second treatment was muscimol or saline into the CVLM.
Four groups of animals (n  8 each group) were also used, and in
each rat only one of the following combinations was tested: 1) Vehicle
into the NTS followed by saline into the CVLM (control); 2) Kyn
Fig. 2. Typical recording showing changes in pulsatile arterial pressure (PAP), mean arterial pressure (MAP), heart rate (HR), renal (RBF), mesenteric (MBF)
and hindquarter (HBF) blood flows produced by bilateral injections of muscimol (120 pmol/50 nl) injected into the CVLM followed by bilateral injections of
kynurenic acid (kyn, 2.7 nmol/50 nl) into the NTS. Arrows indicated the moment of the injections.
Table 1. Baseline MAP and HR in the different groups of
rats that received injections of saline or muscimol into the
caudal ventrolateral medulla and vehicle or kynurenic acid
into the nucleus of the solitary tract
Treatments Baseline MAP, mmHg Baseline HR, bpm
sal  veh 1056 35212
musc  veh 992 34310
sal  kyn 1023 3687
musc  kyn 1033 3409
veh  sal 1012 33416
kyn  sal 1056 3267
veh  musc 1035 33811
kyn  musc 1004 3328
The results are presented as means  SE; n  8 rats for each treatment. sal,
saline; veh, vehicle; musc, muscimol; kyn, kynurenic acid; MAP, mean arterial
pressure; HR, heart rate.
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into the NTS followed by saline into the CVLM; 3) Vehicle into the
NTS followed by muscimol into the CVLM; and 4) Kyn into the NTS
followed by muscimol into the CVLM.
Baroreflex test in rats treated with muscimol into the CVLM and
kynurenic acid into the NTS. In 6 rats that received muscimol into the
CVLM followed by kyn into the NTS, and in 5 rats treated with
injections of kyn into the NTS followed by injections of muscimol
into the CVLM, the baroreflex was tested by intravenous injection of
a pressor dose of phenylephrine (5 g/kg body wt) and a depressor
dose of sodium nitroprusside (30 g/kg body wt). The injections of
phenylephrine and sodium nitroprusside were performed from 4 to 8
min before the first central injection (control) and from 10 to 20 min
after the second central injection.
Effects of kynurenic acid and muscimol injected in sites outside the
NTS and CVLM on MAP, HR, and regional vascular resistances. To
confirm the specificity of injection sites for the effects of muscimol
and kynurenic acid on MAP, HR, and regional vascular resistances,
results from rats in which the injections did not reach the NTS or the
CVLM bilaterally (misplaced injections) were also analyzed and
presented in the RESULTS section.
RESULTS
Histological analysis. Figure 1A is a photomicrograph
showing the typical sites of the bilateral injections into the
intermediate region of the NTS and into the CVLM in one
rat representative of the rats used in the present study.
Figure 1B is a diagrammatic composite showing the injec-
tion sites into the medulla in rats that received injections of
muscimol and kyn. According to Paxinos and Watson (40),
these coronal sections are located 13.7 mm caudal to
bregma. The injection sites in the NTS shown in Fig. 1 are
the same that previous studies have already shown to pro-
duce depressor responses to L-glutamate injections and pres-
sor responses to bilateral injections of kyn (18, 32). Sym-
pathoinhibitory neurons have been described in the CVLM
in sites similar to those shown in Fig. 1 (1, 3, 28, 34),
and previous studies have showed that bilateral injections
of muscimol in these sites induced pressor responses (25,
26, 49).
Changes in MAP, HR, and regional vascular resistances
induced by kynurenic acid into the NTS in rats pretreated with
muscimol into the CVLM. The baseline levels of MAP and HR
were similar in all four experimental groups tested (Table 1).
Bilateral injections of muscimol (120 pmol/50 nl) into the
CVLM followed by vehicle into the NTS resulted in sustained
(for at least 30 min) hypertension (186  11 mmHg vs. saline:
105  4 mmHg), tachycardia [407  15 beats per minute
(bpm) vs. saline: 352  12 bpm] and increase in renal (364 
38% vs. saline: 6  12%), mesenteric (389  53% vs. saline:
8  4%) and hindquarter vascular resistances (403  48% vs.
saline: 7  9%), whereas renal (	123  51% vs. saline: 5 
5%), mesenteric (	184  46% vs. saline: 11  13%) and
hindquarter (	196  47% vs. saline: 8  10%) blood flows
were reduced (Figs. 2 and 3).
Similar to muscimol into the CVLM, bilateral injections
of kyn (2.7 nmol/50 nl) into the NTS preceded by saline into
the CVLM also increased HR to 397  14 bpm. Although
the other responses were less intense than those produced by
muscimol into the CVLM, bilateral injections of kyn into
the NTS also increased MAP to 144  5 mmHg and renal,
mesenteric, and hindquarter vascular resistances, while the
blood flows in the same beds were reduced for at least 30
min (Figs. 2 and 3). However, in rats pretreated with
muscimol into the CVLM, bilateral injections of kyn (2.7
nmol/50 nl) into the NTS immediately reduced MAP to
88  5 mmHg and mesenteric (	28  19%) and hindquar-
ter vascular resistances (	31  11%) below control prein-
jection baseline levels and abolished the changes in renal
vascular resistance but did not modify the effects of mus-
cimol on HR (Figs. 2-4). Mesenteric (33  12%) and
hindquarter (52  16%) blood flows increased to above
control preinjection baseline levels, and renal blood flow
was restored to control baseline level by the combination of
muscimol into the CVLM and kyn into the NTS (Figs. 3 and
4). No significant changes in breathing occurred after injec-
tions of kyn into the NTS or muscimol into the CVLM.
Fig. 3. A: mean arterial pressure (MAP) and (B) heart rate (HR) in rats treated
with bilateral injections of muscimol (mus; 120 pmol/50 nl) or saline into the
CVLM followed by bilateral injections of kynurenic acid (kyn; 2.7 nmol/50 nl)
or vehicle into the NTS. The results are represented as means  SE. n 
number of rats. ANOVA showed significant differences among the treatments
for MAP [F(3, 165)  32.10, P  0.01] and HR [F(3, 165)  43.51, P 
0.01].
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Changes in MAP, HR, and regional vascular resistances
induced by muscimol into the CVLM in rats pretreated with
kynurenic acid into the NTS. The baseline levels of MAP and
HR were similar in all four experimental groups tested (Ta-
ble 1).
Bilateral injections of kyn (2.7 nmol/50 nl) into the NTS
followed by saline into the CVLM produced sustained (for at
least 30 min) increases in MAP (142  6 mmHg vs. vehicle:
101  2 mmHg), HR (412  18 bpm vs. vehicle: 334  16
bpm) and renal (138  13% vs. saline: 8  9%), mesenteric
(168  26% vs. saline: 11  7%) and hindquarter vascular
resistances (154  34% vs. saline: 6  5%), while renal
(	81  19% vs. saline: 	5  15%), mesenteric (	94  21%
vs. saline: 4  6%), and hindquarter (	72  22% vs. saline:
9  14%) blood flows were reduced (Figs. 5 and 6).
Bilateral injections of muscimol (120 pmol/50 nl) into the
CVLM preceded by vehicle into the NTS also increased MAP
to 183 7 mmHg, HR to 443 11 bpm, and renal, mesenteric
and hindquarter vascular resistances, while the blood flows in
the same beds were reduced for at least 30 min (Figs. 5 and 6).
However, bilateral injections of muscimol (120 pmol/50 nl)
into the CVLM in rats pretreated with kyn (2.7 nmol/50 nl) into
the NTS immediately reduced MAP to 92  2 mmHg and
mesenteric (	24  11%) and hindquarter (	26  9%) vas-
cular resistances below control baseline levels and abolished
the changes in renal vascular resistance but not the changes in
Fig. 4. Changes in (A) renal (RVR), (B) mes-
enteric (MVR) and (C) hindquarter (HVR)
vascular resistances and in (D) RBF, (E)
MBF, and (F) HBF produced by bilateral
injections of mus (120 pmol/50 nl) or saline
into the CVLM followed by bilateral injec-
tions of kyn (2.7 nmol/50 nl) or vehicle into
the NTS. The results are represented as
means  SE. n  number of rats. ANOVA
showed significant differences among the
treatments for renal [F(3, 165)  43.19, P 
0.01], mesenteric [F(3, 165)  29.34, P 
0.01], and hindquarter [F(3, 165)  25.24,
P  0.01] vascular resistances and for renal
[F(3, 165)  188.22, P  0.01], mesenteric
[F(3, 165)  179.74, P  0.01], and hind-
quarter [F(3, 165)  171.40, P  0.01] blood
flows.
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HR (Figs. 5-7). Mesenteric (51  14%) and hindquarter (55 
7%) blood flows increased above control preinjection baseline
levels, and renal blood flow was restored to control baseline
level by the combination of kyn into the NTS and muscimol
into the CVLM (Figs. 6 and 7).
Baroreflex test in rats treated with muscimol into the CVLM
and kynurenic acid into the NTS. The combination of bilateral
injections of muscimol into the CVLM and kyn into the NTS
abolished the reflex bradycardia (	1  2 bpm vs. control:
	54  6 bpm; n  11) produced by an intravenous injection
of phenylephrine (5 g/kg body wt) and also abolished the
reflex tachycardia (3  4 bpm vs. control: 66  7 bpm) to
intravenous injection of sodium nitroprusside (30 g/kg body
wt). The pressor response to intravenous phenylephrine (36 
5 mmHg vs. control: 44  9 mmHg) and the hypotension to
intravenous sodium nitroprusside (	35 3 mmHg vs. control:
	37  5 mmHg) were not modified by the simultaneous
blockade of the CVLM with muscimol and the NTS with kyn.
Effects of muscimol and kynurenic acid injected outside the
CVLM and NTS on MAP, HR, and regional vascular resis-
tances. In the first series of experiments, bilateral injections of
muscimol or kyn outside the CVLM or NTS, respectively (Fig.
1), produced no significant changes in the baseline MAP (8 
3 mmHg vs. vehicle: 9  6 mmHg; n  12 and 8, respec-
tively), HR (13  11 bpm vs. vehicle: 7  7 bpm) or renal
(11  6% vs. vehicle: 9  15%), mesenteric (7  5% vs.
vehicle: 12  17%) and hindquarter (6  8% vs. vehicle: 6 
11%) vascular resistances. Injections of kyn outside the NTS
after muscimol into the CVLM produced no additional changes
in MAP (184  11 mmHg vs. vehicle: 188  8 mmHg; n 
12 and 8, respectively), HR (409  11 bpm vs. vehicle: 413 
7 bpm) or renal (345  26% vs. vehicle: 363  32%),
mesenteric (352  35% vs. vehicle: 366  13%) and hind-
quarter (374  51% vs. vehicle: 358  33%) vascular resis-
tances.
In a second series of experiments, the bilateral injections of
kyn or muscimol outside the NTS or CVLM, respectively,
produced no significant changes in the baseline MAP (4  6
mmHg vs. vehicle: 	2  11 mmHg; n  9 and 8, respec-
tively), HR (7  9 bpm vs. vehicle: 13  6 bpm) or renal
(21  16% vs. vehicle: 23  11%), mesenteric (12  5% vs.
vehicle: 11 11%) and hindquarter (9 12% vs. vehicle: 8
9%) vascular resistances. Injections of muscimol outside the
CVLM after kyn into the NTS produced no additional changes
in MAP (144  9 mmHg vs. vehicle: 138  15 mmHg; n 
9 and 8, respectively), HR (417 9 bpm vs. vehicle: 423 16
bpm) or renal (142  36% vs. vehicle: 153  41%), mesen-
teric (162  25% vs. vehicle: 161  13%) and hindquarter
(159  32% vs. vehicle: 158  19%) vascular resistances.
DISCUSSION
As previously demonstrated, the blockade of the glutama-
tergic receptors in the NTS by injections of kyn or the inhibi-
tion of the CVLM with muscimol increases MAP and HR (15,
18, 26, 53). The novelty in the present study is that the
blockade of the glutamatergic receptors of the NTS simulta-
neously with the inhibition of the CVLM reduces MAP and
mesenteric and hindquarter vascular resistances below control
preinjection baseline levels. Misplaced injections of muscimol
or kyn outside the CVLM or NTS produced no significant
changes in the baseline vascular resistances, MAP, and HR.
Therefore, the present results suggest that important pressor
mechanisms arising from the NTS and the CVLM are involved
Fig. 5. Typical recording showing changes in PAP, MAP, HR, RBF, MBF, and HBF blood flows produced by bilateral injections of kyn (2.7 nmol/50 nl) into
the NTS followed by bilateral injections of mus (120 pmol/50 nl) into the CVLM. Arrows indicated the moment of the injections.
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in the control of vascular resistance and arterial pressure in the
conditions used in the present study.
Important connections among the NTS, CVLM, and RVLM
for cardiovascular regulation have been proposed (11, 30).
Chemoreceptors probably activate an excitatory pathway that
connects the NTS to sympathetic premotor neurons in the
RVLM either directly (10, 31, 49) or through brain stem
pathways that involve neurons also in the A5 region (19).
Baroreceptor afferents provide excitatory inputs to second-
order neurons in the NTS that project to the CVLM and
activate inhibitory projections from CVLM to the RVLM (11,
16). Glutamate is suggested to be the neurotransmitter released
by baroreceptor and chemoreceptor afferent fibers in the NTS
(8, 15, 16, 32, 48). Blocking the baroreflex with injections of
kyn into the NTS, the CVLM inhibitory mechanism is deacti-
vated reducing the inhibition of the RVLM which in turn
increases sympathetic activity, vascular resistance, MAP, and
HR. Injections of muscimol into the CVLM also remove the
inhibition of the RVLM producing effects qualitatively similar
to kyn into the NTS (4, 12, 53). Although baroreceptor signals
that arise through NTS are important to inhibit the RVLM (2,
12, 18, 28), it is necessary to consider that part of the inhibition
that the RVLM receives from the CVLM is not baroreceptor
dependent (12), which may explain why vascular resistance
and MAP increases are almost double after CVLM blockade
with muscimol than after only the blockade of the baroreflex
influences with kyn into the NTS.
Although the treatment with muscimol into the CVLM or
kyn into the NTS independently disinhibits the RVLM and
increases sympathetic activity, vascular resistance, MAP, and
HR, when both treatments are combined simultaneously, MAP
and mesenteric and hindquarter vascular resistances fall below
control preinjection levels without changing the HR increase.
These results suggest that the increases in MAP and regional
vascular resistances produced by the inhibition of the CVLM
alone depend on pressor mechanisms arising from the NTS.
Moreover, the effects on MAP and vascular resistances pro-
duced by the blockade of the glutamatergic mechanisms of the
NTS alone depend on pressor mechanisms that arise from the
CVLM. Excitatory mechanisms arising from different central
areas are important to activate RVLM neurons in resting
conditions or hypertensive states (26, 27, 43). Although the
blockade of EAA receptors in the RVLM produces no signif-
icant effects on baseline arterial pressure in rats (18, 26), it
reduces arterial pressure and sympathetic nerve activity in
rabbits (23). Ito and Sved (26) also showed that arterial
pressure was reduced below control resting levels by the
blockade of EAA receptors with kyn in the RVLM combined
with the blockade of the CVLM with muscimol, which sug-
gests that the increase in arterial pressure produced by the
blockade of the CVLM is dependent on RVLM excitation
produced by EAA release. Similar to Ito and Sved (26), the
present results also support the importance of facilitatory
mechanisms to the RVLM for the pressor response, resulting
from muscimol into the CVLM, with the difference that the
present results suggest that the facilitatory projection to the
RVLM arises and is activated by glutamatergic mechanisms in
the NTS.
The existence of pressor mechanisms in the NTS is sug-
gested by the pressor responses usually produced by L-gluta-
mate injections into the NTS in awake rats or by the anti-
hypertensive effects of commissural NTS lesions in spontane-
ously hypertensive rats (9, 33, 42, 44). Although L-glutamate
injected into the NTS in anesthetized rats usually induces
depressor responses, the same injection into the NTS after the
blockade of the CVLM with muscimol produces pressor re-
sponses in anesthetized rats (49), which suggest that L-gluta-
mate injections into the NTS may also activate pressor mech-
anisms in anesthetized rats. However, in anesthetized rats the
pressor mechanism activated by L-glutamate injections into the
NTS is completely masked by the larger depressor responses
dependent on CVLM. Anatomical and imunohistochemical
studies have suggested the existence of a direct excitatory
projection from the NTS to the RVLM (49, 50), which may
convey peripheral chemoreceptor signals (30, 31). Although
kyn injections into the NTS might block chemoreflex pathways
(6, 7, 51), it is necessary to consider that chemoreceptors are
usually silent in the absence of a proper stimulus. Therefore,
Fig. 6. A: MAP and (B) HR in rats treated with bilateral injections of kyn (2.7
nmol/50 nl) or vehicle into the NTS followed by bilateral injection of mus (120
pmol/50 nl) or saline into the CVLM. The results are represented as means 
SE. n  number of rats. ANOVA showed significant differences among the
treatments for MAP [F(3, 165)  26.15, P  0.01] and HR [F(3, 165) 
19.73, P  0.01].
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during the blockade of the CVLM with muscimol, a mecha-
nism probably not related to the chemoreflex seems to activate
EAA receptors in the NTS causing sympathetic activation and
pressor responses. A previous study suggested that aortic
depressor nerve activity can stimulate pressor mechanisms and
increase arterial pressure when the CVLM was blocked by
muscimol (52). Although the involvement of mechanisms
related to the aortic depressor nerve should be considered, the
present results do not illuminate the mechanism that activates
NTS glutamatergic pressor pathways after muscimol injections
into the CVLM. However, it is clear that MAP and vascular
resistance are strongly dependent on NTS glutamatergic mech-
anisms after the blockade of the CVLM. On the other hand, the
pressor response produced by kyn injections into the NTS is
abolished by muscimol injections into the CVLM, suggesting
that excitatory mechanisms from the CVLM blocked by mus-
cimol injections are involved in the pressor response to kyn
injections into the NTS. Injections of kyn into the RVLM
abolish the pressor response to muscimol injections into the
NTS (26), which suggests that the excitatory projection to the
RVLM arises from other sources in addition to the NTS.
Similar to previous studies (26, 38), the present results showing
Fig. 7. Changes in (A) RVR, (B) MVR, and
(C) HVR vascular resistances and in (D)
RBF, (E) MBF, and (F) HBF blood flows
produced by bilateral injections of kyn (2.7
nmol/50 nl) or vehicle into the NTS followed
by bilateral injection of mus (120 pmol/50 nl)
or saline into the CVLM. The results are
represented as means  SE; n  number of
rats. ANOVA showed significant differences
among the treatments for renal [F(3, 165) 
43.63, P  0.01], mesenteric [F(3, 165) 
28.51, P  0.01], and hindquarter [F(3,
165)  32.44, P  0.01] vascular resistances
and renal [F(3, 165)  145.87, P  0.01],
mesenteric [F(3, 165)  256.82, P  0.01],
and hindquarter [F(3, 165)  241.62, P 
0.01] blood flows.
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that the pressor response to kyn injections into the NTS is
abolished by muscimol injections into the CVLM also suggest
that the CVLM by direct or indirect projections may activate
RVLM neurons. Other studies have already suggested that
nonglutamatergic excitatory projections arise from the CVLM
to the RVLM (26) and that the cardiovascular effects of the
caudal pressor area (CPA) activation also depend on an exci-
tatory projection from the CVLM to the RVLM (38).
It is important to note that independent of the sequence of
the CVLM and NTS blockades, HR increased after the first
blockade, and this increase was not affected by the second
blockade. Therefore, the fact that dual blockade produced
different effects on MAP and HR suggests that different
brainstem mechanisms are activated in these responses and
may also involve changes in parasympathetic activity for the
tachycardic responses. It is also important to consider that the
combination of muscimol into the CVLM and kyn into the
NTS reduced mesenteric and hindquarter vascular resistances
below control baseline levels, while renal vascular resistance
was maintained at the baseline level, which suggests that the
hypotension after the combination of the two treatments de-
pends on vasodilation of specific vascular beds. Although NTS
glutamatergic and CVLM excitatory mechanisms are important
for the increase in renal, mesenteric and hindquarter vascular
resistances after the blockade of each area individually, these
excitatory mechanisms apparently are not important to main-
tain baseline renal vascular resistance when both areas are
blocked simultaneously. This differs from hindquarter and
mesenteric vascular resistances that are dependent on NTS and
CVLM excitatory mechanisms to maintain resting levels.
In conclusion, the present results suggest that the pressor
responses produced by the blockade of the inhibitory mecha-
nism to the RVLM are strongly dependent on the excitatory
projections that arise from the CVLM and from the NTS. In
addition, these excitatory pressor mechanisms are also impor-
tant to maintain baseline arterial pressure and vascular resis-
tance because the blockade of both mechanisms simulta-
neously reduced MAP and vascular resistance to below control
resting levels
Perspectives
One important mechanism still not completely understood is
how RVLM neurons are activated to maintain tonic baseline
activity of sympathetic nervous system. Besides the impor-
tance of the inhibitory mechanisms to control RVLM and
sympathetic activity, recent studies have suggested that exci-
tatory projections to the RVLM seem to play an important role
in cardiovascular regulation. The present results suggest that
excitatory mechanisms that arise from the NTS and CVLM are
important to activate RVLM and the sympathetic system. In
addition, they suggest that a balance between NTS and CVLM
excitatory and inhibitory mechanisms seems to be essential to
maintain baseline arterial pressure. Studies using different
methodologies are necessary to show more details and to
establish the role of the excitatory mechanisms proposed in the
present study in the control of sympathetic activity and arterial
pressure. An important mechanism still not understood is how
the excitatory projections from CVLM and NTS to RVLM are
activated under physiological conditions. Other questions for
further investigation include whether the pathway relaying
excitatory signals from the NTS to RVLM is also involved in
chemoreceptor signaling and whether baroreceptor signaling is
involved in the cardiovascular responses evoked from NTS
when the CVLM is blocked by muscimol.
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